Macular disease

European drug regulators have followed in the footsteps of their Australian and US counterparts, following the approval of Novartis’ new...

The UK’s national health provider has started treating patients with Leber's Congenital Amaurosis (LCA) with a new sight-restoring gene therapy....

A former backpacker accommodation is being transformed into a new eye health clinic in Broome, featuring three resident ophthalmologists available...

A surgeon at the University of Pittsburgh Medical Center (UPMC) has implanted the first patient in the US with a...

A Melbourne researcher has received a major funding boost to progress development of a tissue-engineered corneal endothelium for transplant, which...

In a discovery that could have significant implications for how age-related ocular diseases are diagnosed and treated, researchers have pinpointed...

A new study has demonstrated that a particular biomarker can be used to select which age-related macular degeneration (AMD) patients...

Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the...

Melbourne biopharmaceutical company Opthea has completed the patient recruitment phase for the latest trial of its novel therapy for diabetic...

An Australian-led study has received $5 million to undertake the world’s most intensive investigation into why a particular group of...